I. Verma

发表

Dedifferentiation and reprogramming: origins of cancer stem cells

D. Friedmann-Morvinski, I. Verma, Inder M. Verma, 2014, EMBO reports.

Enhanced NF-kappaB activation and cellular function in macrophages lacking IkappaB kinase 1 (IKK1).

I. Verma, Qiutang Li, Qingxian Lu, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Enhanced NF-κB activation and cellular function in macrophages lacking IκB kinase 1 (IKK1)

Inder M. Verma, Qingxian Lu, I. Verma, 2005 .

Suppression of TNF-alpha-induced apoptosis by NF-kappaB.

D. Green, I. Verma, S. Martin, 1996, Science.

A tumultuous year for gene therapy.

I. Verma, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

[35] – Cationic Liposome-Mediated RNA Transfection

I. Verma, R. Malone, V. Dwarki, 1995 .

Cationic liposome-mediated RNA transfection.

I. Verma, R. Malone, P. Felgner, 1989, Proceedings of the National Academy of Sciences of the United States of America.

In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector

F. Gage, I. Verma, D. Trono, 1996, Science.

Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector.

F. Gage, I. Verma, F. Gage, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Transduction of human CD34+ cells that mediate long-term engraftment of NOD/SCID mice by HIV vectors.

B. Torbett, I. Verma, H. Miyoshi, 1999, Science.

Gene therapy - promises, problems and prospects

I. Verma, N. Somia, 1997, Nature.

NF-κB regulation in the immune system

I. Verma, Qiutang Li, I. M. Verma, 2002, Nature Reviews Immunology.

Light-sheet Bayesian microscopy enables deep-cell super-resolution imaging of heterochromatin in live human embryonic stem cells

Ying S Hu, Y. Li, I. Verma, 2013, Optical Nanoscopy.

Transparency in authors’ contributions and responsibilities to promote integrity in scientific publication

Barbara Kline Pope, R. Schekman, V. Kiermer, 2017, Proceedings of the National Academy of Sciences.

Gene therapy: twenty-first century medicine.

M. Weitzman, I. Verma, 2005, Annual review of biochemistry.

Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases

K S Kosik, D. Rowitch, K. Kosik, 2012, Oncogene.

Intercellular Coupling Confers Robustness against Mutations in the SCN Circadian Clock Network

Francis J. Doyle, Steve A. Kay, Joseph S. Takahashi, 2007, Cell.

Adeno-associated virus effectively mediates conditional gene modification in the brain

Fred H. Gage, Brian K. Kaspar, Inder M. Verma, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Autoregulation of I kappa B alpha activity.

I. Verma, P. Chiao, S. Miyamoto, 1994, Proceedings of the National Academy of Sciences of the United States of America.

R~~/NF-KB /IKB familv: intimate tales of association and dissociation

Inder M. Verma, I. Verma, E. Schwarz, 1995 .

Constitutive phosphorylation of I kappa B alpha by casein kinase II.

I. Verma, E. Schwarz, C. Barroga, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Constitutive phosphorylation of IkappaBalpha by casein kinase II occurs preferentially at serine 293: requirement for degradation of free IkappaBalpha

I. Verma, E. Schwarz, D. V. Van Antwerp, 1996, Molecular and cellular biology.

CtIP links DNA double-strand break sensing to resection.

Linda Z. Shi, Linda Z Shi, Michael W Berns, 2009, Molecular cell.

BRCA1 tumor suppression occurs via heterochromatin mediated silencing

Fred H. Gage, Gerald M. Pao, Inder M. Verma, 2011, Nature.

Cationic liposome-mediated RNA transfection.

I. Verma, R. Malone, V. Dwarki, 1993, Methods in enzymology.

BRCA1 Is Phosphorylated at Serine 1497 In Vivo at a Cyclin-Dependent Kinase 2 Phosphorylation Site

Heinz Ruffner, Inder M. Verma, Tony Hunter, 1999, Molecular and Cellular Biology.

NF-kappaB regulation in the immune system.

Inder M Verma, I. Verma, Qiutang Li, 2002, Nature reviews. Immunology.

Gene therapy: trials and tribulations

Inder M. Verma, I. Verma, N. Somia, 2000, Nature Reviews Genetics.

A transmissible retrovirus expressing human hypoxanthine phosphoribosyltransferase (HPRT): gene transfer into cells obtained from humans deficient in HPRT.

I. Verma, A. Miller, T. Friedmann, 1983, Proceedings of the National Academy of Sciences of the United States of America.

Negative and positive regulation by transcription factor cAMP response element-binding protein is modulated by phosphorylation.

I. Verma, M. Montminy, R. Ofir, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Telomere-independent Rap1 is an IKK adaptor and regulates NF-κB-dependent gene expression

Sumit K. Chanda, Hendrik Luesch, Vinay Tergaonkar, 2010, Nature Cell Biology.

Dedifferentiation of Neurons and Astrocytes by Oncogenes Can Induce Gliomas in Mice

Eric A Bushong, Mark H Ellisman, Eugene Ke, 2012, Science.

Design and cloning of lentiviral vectors expressing small interfering RNAs

I. Verma, O. Singer, G. Tiscornia, 2006, Nature Protocols.

Differential transcription of exon 1 of the human c-fms gene in placental trophoblasts and monocytes

J. Visvader, I. Verma, 1989 .

Growth hormone-releasing factor induces c-fos expression in cultured primary pituitary cells.

R. Mitchell, I. Verma, N. Billestrup, 1987, Molecular endocrinology.

c-fos expression is neither sufficient nor obligatory for differentiation of monomyelocytes to macrophages

R. Mitchell, I. Verma, E. Huberman, 1986, Cell.

Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus

Inder M. Verma, Clare M. Isacke, E. Chen, 1986, Nature.

Transcription of c-onc genes c-rasKi and c-fms during mouse development

I. Verma, D. Slamon, E. Adamson, 1983, Molecular and cellular biology.

Expression cloning of human EGF receptor complementary DNA: gene amplification and three related messenger RNA products in A431 cells.

R. Evans, M. Rosenfeld, I. Verma, 1984, Science.

Phosphorylation of the C terminus of Fos protein is required for transcriptional transrepression of the c-fos promoter

I. Verma, R. Ofir, V. Dwarki, 1990, Nature.

Zebrafish IκB Kinase 1 Negatively Regulates NF-κB Activity

Concepción Rodríguez-Esteban, I. Verma, R. G. Correa, 2005, Current Biology.

Cleavage of the leptin receptor by matrix metalloproteinase–2 promotes leptin resistance and obesity in mice

G. Schmid-Schönbein, D. Friedmann-Morvinski, I. Verma, 2018, Science Translational Medicine.

Immunological defects in mice with a targeted disruption in Bcl-3.

I. Verma, E. Schwarz, A. Berns, 1997, Genes & development.

A fourth IkappaB protein within the NF-kappaB signaling module.

Hana Kim, Alexander Hoffmann, Vinay Tergaonkar, 2007, Cell.

Astrocytes contribute to gamma oscillations and recognition memory

Terrence J. Sejnowski, Xin Wang, Inder M. Verma, 2014, Proceedings of the National Academy of Sciences.

Circulating human or canine factor IX from retrovirally transduced primary myoblasts and established myoblast cell lines grafted into murine skeletal muscle

R. Naviaux, I. Verma, T. Friedmann, 1992, Somatic cell and molecular genetics.

Gene therapy via primary myoblasts: long-term expression of factor IX protein following transplantation in vivo.

R. Naviaux, I. Verma, Inder M. Verma, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Proto-oncogene fos: a multifaceted gene

I. Verma, 1986 .

Restoration of spermatogenesis by lentiviral gene transfer: Offspring from infertile mice

I. Verma, M. Ikawa, N. Ogonuki, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Modulation of c-"os gene transcription by negative and positive cellular factors

I. Verma, P. Sassone-Corsi, 1987, Nature.

An alternative spliced form of FosB is a negative regulator of transcriptional activation and transformation by Fos proteins.

I. Verma, R. Wisdom, I. Tratner, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Generation of multiciliated cells in functional airway epithelia from human induced pluripotent stem cells

F. Gage, I. Verma, A. Firth, 2014, Proceedings of the National Academy of Sciences.

Genome organization of retroviruses IX. Analysis of the genomes of Friend spleen focus-forming (F-SFFV) and helper murine leukemia viruses by heteroduplex-formation.

I. Verma, I M Verma, L. V. van Griensven, 1980, Virology.

Genome organization of RNA tumor viruses. I. In vitro synthesis of full-genome-length single-stranded and double-stranded viral DNA transcripts

I. Verma, 1978, Journal of virology.

Genome Organization of Retroviruses V. In Vitro-Synthesized Moloney Murine Leukemia Viral DNA Has Long Terminal Redundancy

I. Verma, R. Bosselman, 1980, Journal of virology.

Efficient insertion of genes into the mouse germ line via retroviral vectors.

R. Evans, M. Rosenfeld, I. Verma, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Elements in the long terminal repeat of murine retroviruses enhance stable transformation by thymidine kinase gene.

I. Verma, T. Friedmann, S. Subramani, 1983, Nucleic acids research.

Systemic delivery of factor IX messenger RNA for protein replacement therapy

I. Verma, Nina Tonnu, P. Karmali, 2017, Proceedings of the National Academy of Sciences.

Gene therapy: Therapeutic gene causing lymphoma

I. Verma, V. Bottero, Manfred Schmidt, 2006, Nature.

Effect of adenovirus-mediated overexpression of follistatin and extracellular domain of activin receptor type II on gonadotropin secretion in vitro and in vivo.

C. Donaldson, I. Verma, Lili Wang, 2002, Endocrinology.

Phosphorylation of SNAP-23 by IκB Kinase 2 Regulates Mast Cell Degranulation

I. Verma, Kotaro Suzuki, 2008, Cell.

Activation of Transcription Factor NF-κB Requires ELKS, an IκB Kinase Regulatory Subunit

A. Shevchenko, I. Verma, V. Bottero, 2004, Science.

A factor IX-deficient mouse model for hemophilia B gene therapy.

M. Zoppè, I. Verma, J. Griffin, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Regulated mRNA stability.

I. Verma, R. Wisdom, Inder M. Verma, 1990, Annual review of genetics.

Generation of targeted retroviral vectors by using single-chain variable fragment: an approach to in vivo gene delivery.

M. Zoppè, I. Verma, N. Somia, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Proposed NF-κB/IκB family nomenclature

G. Nabel, I. Verma, 1993 .

SNW1, a Novel Transcriptional Regulator of the NF-κB Pathway

S. Chanda, I. Verma, S. Verma, 2018, Molecular and Cellular Biology.

Characterization of NF-κΒ/IκΒ Proteins in Zebra Fish and Their Involvement in Notochord Development

I. Verma, R. G. Correa, V. Tergaonkar, 2004, Molecular and Cellular Biology.

p53 stabilization is decreased upon NFkappaB activation: a role for NFkappaB in acquisition of resistance to chemotherapy.

G. Wahl, I. Verma, O. Vafa, 2002, Cancer cell.

Gene therapy: beyond 2000.

I. Verma, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

References and Notes

Karin, D. Baltimore, M. Scott, 2021, The World Before Us.

Targeting NF-κB in glioblastoma: A therapeutic approach

D. Friedmann-Morvinski, I. Verma, Y. Soda, 2016, Science Advances.

RNA Interference Technology: siRNA delivery by lentiviral vectors: Design and applications

I. Verma, O. Singer, G. Tiscornia, 2005 .

Direct involvement of the ubiquitin-conjugating enzyme Ubc9/Hus5 in the degradation of IκBα

S. Inoue, I. Verma, M. Pando, 1997 .

Viral and Cellular Fos Gene

T. Curran, I. Verma, A. Miller, 1985 .

Two base changes restore infectivity to a noninfectious molecular clone of Moloney murine leukemia virus (pMLV-1)

I. Verma, A. Miller, I M Verma, 1984, Journal of virology.

The proto-oncogene bcl-3 encodes an I kappa B protein.

G. Nabel, I. Verma, C. Duckett, 1992, Genes & development.

FBR murine osteosarcoma virus. I. Molecular analysis and characterization of a 75,000-Da gag-fos fusion product.

T. Curran, I. Verma, 1984, Virology.

centrosome duplication to once per cell cycle The autoregulated instability of Polo-like kinase 4 limits Material Supplemental

I. Verma, Quan-sheng Zhu, E. Nigg, 2013 .

The autoregulated instability of Polo-like kinase 4 limits centrosome duplication to once per cell cycle.

I. Verma, Quan-sheng Zhu, E. Nigg, 2012, Genes & development.

Polo-like kinase 4 controls centriole duplication but does not directly regulate cytokinesis

I. Verma, Quan-sheng Zhu, M. Bettencourt-Dias, 2012, Molecular biology of the cell.

Antiapoptotic Role for Lifeguard in T Cell Mediated Immune Response

I. Verma, Fei Liu, Tatiana Hurtado de Mendoza, 2015, PloS one.

A Neuroprotective Brain-penetrating Endopeptidase Fusion Protein Ameliorates Alzheimer Disease Pathology and Restores Neurogenesis*

E. Masliah, I. Verma, E. Rockenstein, 2014, The Journal of Biological Chemistry.

Structural Basis for the Activation of IKK1/α

I. Verma, G. Ghosh, D. Lyumkis, 2016, Cell reports.

Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival.

T. Hunter, I. Verma, V. Bottero, 2006, Cancer cell.

Essential role of tuberous sclerosis genes TSC 1 and TSC 2 in NFk B activation and cell survival

T. Hunter, I. Verma, V. Bottero, 2022 .

Nuclear factor (NF)-κB proteins: therapeutic targets*

I. Verma, I. M. Verma, 2004 .

Inhibition of TNF-induced apoptosis by NF-kappa B.

D. Green, I. Verma, S. Martin, 1998, Trends in cell biology.

Developmental Expression of the Xenopus Iaevis fos

I. Verma, M. Kindy, 2005 .

Targeted delivery of proteins across the blood–brain barrier

I. Verma, B. Spencer, 2007, Proceedings of the National Academy of Sciences.

Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis.

N. Sarvetnick, I. Verma, T. Kafri, 1998, Human gene therapy.

Gene Therapy: Hopes, Hypes, and Hurdles

I. Verma, 1994, Molecular medicine.

An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma

Mariella G. Filbin, McKenzie L. Shaw, Lisa Mayr, 2019, Cell.

Proto-oncogene expression in regenerating liver is simulated in cultures of primary adult rat hepatocytes.

I. Verma, H. van der Putten, H. Leffert, 1986, The Journal of biological chemistry.

Cellular immune response to adenoviral vector infected cells does not require de novo viral gene expression: implications for gene therapy.

N. Sarvetnick, I. Verma, T. Kafri, 1998, Proceedings of the National Academy of Sciences of the United States of America.

Differential transcription of exon 1 of the human c-fms gene in placental trophoblasts and monocytes

J. Visvader, I. Verma, Inder M. Verma, 1989, Molecular and cellular biology.

Expression of FBJ-MSV oncogene (fos) product in bacteria.

I. Verma, W. Macconnell, 1983, Virology.

Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice.

I. Verma, J. Olefsky, M. Saberi, 2009, Cell metabolism.

Signal transduction: the nuclear target.

I. Verma, J. Inoue, Inder M. Verma, 1992, Current opinion in cell biology.

Expression of the c-fos gene during differentiation.

R. Mitchell, I. Verma, E. Huberman, 1987, Advances in experimental medicine and biology.

Brief Report: Efficient Generation of Hematopoietic Precursors and Progenitors from Human Pluripotent Stem Cell Lines

F. Gage, K. Brennand, J. C. Belmonte, 2011, Stem cells.

Purified I kappa B-beta is inactivated upon dephosphorylation.

U. Zabel, I. Verma, P. Baeuerle, 1992, The Journal of biological chemistry.

The reverse transcriptase.

I. Verma, 1977, Biochimica et biophysica acta.

Expression of a retrovirus encoding human HPRT in mice.

I. Verma, A. Miller, T. Friedmann, 1984, Science.

Human purine nucleoside phosphorylase and adenosine deaminase: gene transfer into cultured cells and murine hematopoietic stem cells by using recombinant amphotropic retroviruses

S. Williams, I. Verma, M. J. Johnson, 1987, Molecular and cellular biology.

Transformation by Fos proteins requires a C-terminal transactivation domain

I. Verma, R. Wisdon, 1993, Molecular and cellular biology.

Alteration of a cyclic AMP-dependent protein kinase phosphorylation site in the c-Fos protein augments its transforming potential

I. Verma, R. Ofir, I. Tratner, 1992, Molecular and cellular biology.

Sustained correction of bleeding disorder in hemophilia B mice by gene therapy.

S. Bidlingmaier, I. Verma, C. Ill, 1999, Proceedings of the National Academy of Sciences of the United States of America.

A role for IkappaB kinase 2 in bipolar spindle assembly.

Yingyao Zhou, J. Irelan, L. Miraglia, 2007, Proceedings of the National Academy of Sciences of the United States of America.

Regulation of beta-catenin function by the IkappaB kinases.

R. Gaynor, S. Byers, I. Verma, 2001, The Journal of biological chemistry.

Structure of Moloney murine leukemia viral DNA: nucleotide sequence of the 5' long terminal repeat and adjacent cellular sequences.

I. Verma, A. Berns, C. V. van Beveren, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Revertants of v-fos-transformed rat fibroblasts: suppression of transformation is dominant

I. Verma, R. Wisdom, 1990, Molecular and cellular biology.

Domain swapping reveals the modular nature of Fos, Jun, and CREB proteins

I. Verma, K. Morley, L. Ransone, 1990, Molecular and cellular biology.

Characterization and purification of human fos protein generated in insect cells with a baculoviral expression vector

I. Verma, P. Sassone-Corsi, I. Tratner, 1990, Journal of virology.

fos-jun conspiracy: implications for the cell.

J. Visvader, I. Verma, P. Sassone-Corsi, 1990, Ciba Foundation symposium.

Gene regulation by tyrosine kinases: src protein activates various promoters, including c-fos

I. Verma, D. Shalloway, M. Fujii, 1989, Molecular and cellular biology.

Modification of fos proteins: phosphorylation of c-fos, but not v-fos, is stimulated by 12-tetradecanoyl-phorbol-13-acetate and serum

I. Verma, J. Barber, 1987, Molecular and cellular biology.

Genome organization of retroviruses. VIII. Nonproducer cell lines of mouse fibroblasts transformed by Moloney murine sarcoma virus DNA synthesized in vitro.

I. Verma, M. Lai, 1980, Virology.

Enhanced IKBot Degradation Is Responsible for Constitutive NF-KB Activity in Mature Murine B-Cell Lines

I. Verma, P. Chiao, S. Miyamoto, 2022 .

DNA polymerase activity from two temperature-sensitive mutants of Rous sarcoma virus is thermolabile

D. Baltimore, I. Verma, W. Mason, 1974, Nature.

Hypothesis-driven science.

I. Verma, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

M-MuLV-induced leukemogenesis: Integration and structure of recombinant proviruses in tumors

W. Quint, I. Verma, A. Berns, 1981, Cell.

Molecular cloning of unintegrated and a portion of integrated moloney murine leukemia viral DNA in bacteriophage lambda

L. Bacheler, I. Verma, A. Berns, 1980, Journal of virology.

Proto-oncogene FosB: the amino terminus encodes a regulatory function required for transformation

I. Verma, R. Wisdom, 1993, Molecular and cellular biology.

Transcriptional induction of the murine c-rel gene with serum and phorbol-12-myristate-13-acetate in fibroblasts

T. Hunter, I. Verma, Inder M. Verma, 1989, Molecular and cellular biology.

An alternative approach to somatic cell gene therapy.

I. Verma, Inder M. Verma, D. S. St. Louis, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Adenovirus‐mediated overexpression of follistatin enlarges intact liver of adult rats

I. Verma, Lili Wang, W. Vale, 2003, Hepatology.

Synthesis of DNA complementary to cellular slime mold messenger RNA by reverse transcriptase.

H. Lodish, D. Baltimore, I. Verma, 1974, Biochemistry.

Repopulation of adult and neonatal mice with human hepatocytes: A chimeric animal model

I. Verma, K. Bissig, N. Woods, 2007, Proceedings of the National Academy of Sciences.

Generation of helper-free amphotropic retroviruses that transduce a dominant-acting, methotrexate-resistant dihydrofolate reductase gene

I. Verma, A. Miller, M. Law, 1985, Molecular and cellular biology.

Oncogenic intelligence: From c-fos to v-fos

I. Verma, 1984, Nature.

Deletion of the gag region from FBR murine osteosarcoma virus does not affect its enhanced transforming activity

T. Curran, I. Verma, A. Miller, 1985, Journal of virology.

MOLECULAR CLONING OF MOLONEY MOUSE SARCOMA VIRUS SPECIFIC SEQUENCES FROM UNINFECTED MOUSE CELLS

I. Verma, A. Berns, H. Fan, 1980 .

Signal-dependent and -independent degradation of free and NF-kappa B-bound IkappaBalpha.

I. Verma, M. Pando, 2000, The Journal of biological chemistry.

NF-kBActivation Upregulates PKM2 Expression and Promotes Tumorigenesis

K. Aldape, T. Kornberg, I. Verma, 2018 .

Models and Open Questions Pulmonary Surfactant Pathophysiology: Current

Kevin J. McHugh, J. Alcorn, Jianhua Fu, 2015 .

Cationic liposome-mediated RNA transfection [ cationic lipid vesicies / N-[ 1-( 2 , 3-dioleyloxy ) propyl ]-NNN-timethylammonium chloride ( DOTMA ) / translationj

I. Verma, R. Malone, P. Felgner, 2022 .

Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs.

I. Verma, M. Read, K. Brinkhous, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Autologous and Heterologous Cell Therapy for Hemophilia B toward Functional Restoration of Factor IX

Kevin T. Green, I. Verma, P. Monahan, 2018, Cell reports.

Nerve growth factor induces neuron-like differentiation of an insulin-secreting pancreatic beta cell line.

R. Scharfmann, M. Polak, I. Verma, 1993, Proceedings of the National Academy of Sciences of the United States of America.

The Rel-associated pp40 protein prevents DNA binding of Rel and NF-KB: relationship .with IKBI3 and regulation by phosphorylatlon

Lawrence, I. Verma, H. Bose,, 2007 .

Erratum: Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis (The Journal of Clinical Investigation (2013) 123:1 (405-417) (DOI: 10.1172/JCI63811)

K. Aldape, A. Iavarone, P. Zoppoli, 2014 .

Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation.

E M Schwarz, I. Verma, E. Schwarz, 1995, Genes & development.

c-fos promoter trans-activation by the tax1 protein of human T-cell leukemia virus type I.

I. Verma, P. Sassone-Corsi, M. Fujii, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Nucleotide sequences of human globin messenger RNA.

S. Weissman, D. Baltimore, I. Verma, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Retroviral vectors for persistent expression in vivo.

R. Naviaux, I. Verma, 1992, Current opinion in biotechnology.

c-rel activates but v-rel suppresses transcription from kappa B sites.

T. Hunter, I. Verma, J. Inoue, 1991, Proceedings of the National Academy of Sciences of the United States of America.

A comparison of nucleotide sequences from mitochondrial and cytoplasmic ribosomal RNA of Aspergillus nidulans.

M. Edelman, I. Verma, U. Z. Littauer, 1971, European journal of biochemistry.

Gene therapy: reality or myth for the global bleeding disorders community?

I. Verma, G. Pierce, K. Kelley, 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

Retrovirus-mediated gene transfer into embryonal carcinoma and hemopoietic stem cells: expression from a hybrid long terminal repeat.

I. Verma, D. Valerio, C. Li, 1989, Gene.

Mammalian retrovirus-associated RNase H is virus coded

I. Verma, S. Aaronson, S. Tronick, 1978, Journal of virology.

Characterization of "early" temperature-sensitive mutants of avian sarcoma viruses: biological properties, thermolability of reverse transcriptase in vitro, and synthesis of viral DNA in infected cells.

H. Varmus, I. Verma, E. Hunter, 1976, Virology.

Thermolabile reverse transcriptase of a mammalian leukemia virus mutant temperature sensitive in its replication and sarcoma virus helper functions

J. Stephenson, I. Verma, S. Aaronson, 1975, Journal of virology.

Studies on reverse transcriptase of RNA tumor viruses III. Properties of purified Moloney murine leukemia virus DNA polymerase and associated RNase H

I. Verma, 1975, Journal of virology.

Studies on reverse transcriptase of RNA tumor viruses. I. Localization of thermolabile DNA polymerase and RNase H activities on one polypeptide

I. Verma, 1975, Journal of virology.

Properties and Origin of the Subunits of Reverse Transcriptase Isolated from Avian RNA Tumor Viruses

D. Baltimore, I. Verma, A. Panet, 1975 .

Studies on the reverse transcriptase of RNA tumor viruses. Structural relatedness of two subunits of avian RNA tumor viruses.

I. Verma, W. Gibson, 1974, Proceedings of the National Academy of Sciences of the United States of America.

Temperature‐sensitive dna polymerase from rous sarcoma virus mutants

D. Baltimore, I. Verma, W. Mason, 1974, Cancer.

Hamster Leukemia Virus: Lack of Endogenous DNA Synthesis and Unique Structure of Its DNA Polymerase

D. Baltimore, I. Verma, H. Fan, 1974, Journal of virology.

Lymphoid regeneration from gene-corrected SCID-X1 subject-derived iPSCs.

I. Verma, I. Alexander, A. Firth, 2015, Cell stem cell.

Lymphoid Regeneration fr om Gene-Corrected SCID-X 1 Subject-Derived iPSCs Graphical Abstract Highlights

I. Verma, I. Alexander, A. Firth, 2015 .

CREB represses transcription of fos promoter: role of phosphorylation.

I. Verma, R. Ofir, V. Dwarki, 1991, Gene expression.

Constitutive Phosphorylation of Ikappabalpha

I. Verma, E. Schwarz, D. V. Antwerp, 1996 .

Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector.

F. Gage, I. Verma, F. Gage, 1997, Proceedings of the National Academy of Sciences of the United States of America.

The Knockout Mouse Project

Christopher P Austin, Brian Seed, Jay Snoddy, 2004, Nature Genetics.

The pCL vector system: rapid production of helper-free, high-titer, recombinant retroviruses

R. Naviaux, I. Verma, M. Haas, 1996, Journal of virology.

Nuclear factor (NF)-kappaB proteins: therapeutic targets.

I. Verma, 2004, Annals of the rheumatic diseases.

Stem cells at the dawn of the 21st century

F. Gage, I. Verma, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Generation of transgenic mice using lentiviral vectors: a novel preclinical assessment of lentiviral vectors for gene therapy.

W. Kao, N. Tanaka, I. Verma, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

Cross-talk in signal transduction: TPA-inducible factor jun/AP-1 activates cAMP-responsive enhancer elements.

I. Verma, P. Sassone-Corsi, Inder M. Verma, 1990, Oncogene.

Removal of a 67-base-pair sequence in the noncoding region of protooncogene fos converts it to a transforming gene.

T. Curran, I. Verma, A. Miller, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Human gene therapy.

R. Naviaux, I. Verma, 1991, Current opinion in genetics & development.

Towards Gene Therapy for Adenosine Deaminase Deficiency

I. Verma, R. Kellems, D. Valerio, 1989 .

Trans-dominant negative mutants of Fos and Jun.

J. Visvader, I. Verma, Inder M. Verma, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Organotypic Cerebellar Cultures: Apoptotic Challenges and Detection

I. Verma, P. Slesinger, Tatiana Hurtado de Mendoza, 2011, Journal of visualized experiments : JoVE.

Purification of the RNA-directed DNA polymerase from avian myeloblastosis virus and its assay with polynucleotide templates.

D. Baltimore, I. Verma, 1974, Methods in enzymology.

Synthesis of DNA complementary to 14S calf lens crystallin messenger RNA by reverse transcriptase.

I. Verma, A. Berns, S. Kaufman, 1973, Biochemical and biophysical research communications.

Proposed NF-kappa B/I kappa B family nomenclature.

G. Nabel, I. Verma, 1993, Genes & development.

Adverse event reporting: essential for science and public trust.

I. Verma, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

A role for IκB kinase 2 in bipolar spindle assembly

Yingyao Zhou, J. Irelan, L. Miraglia, 2007, Proceedings of the National Academy of Sciences.

Applications of lentiviral vectors for shRNA delivery and transgenesis.

I. Verma, O. Singer, 2008, Current gene therapy.

Retinoic acid is a negative regulator of AP-1-responsive genes.

S. Kliewer, P. Rangarajan, R. Evans, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Reciprocal Role of ERK and Nf-κb Pathways in Survival and Activation of Osteoclasts

Kozo Nakamura, Sakae Tanaka, I. Verma, 2000, The Journal of cell biology.

Sustained correction of disease in naive and AAV2-pretreated hemophilia B dogs: AAV2/8-mediated, liver-directed gene therapy.

Lili Wang, I. Verma, James M. Wilson, 2005, Blood.

Sustained expression of therapeutic level of factor IX in hemophilia B dogs by AAV-mediated gene therapy in liver.

I. Verma, D. Bellinger, T. Nichols, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Towards gene therapy for hemophilia B.

I. Verma, A. Miller, G. Brownlee, 1987, Molecular biology & medicine.

Efficient production of human FVIII in hemophilic mice using lentiviral vectors.

I. Verma, N. Kootstra, Ryusuke Matsumura, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

NF-κB, an Active Player in Human Cancers

Inder M. Verma, I. Verma, Yifeng Xia, 2014, Cancer Immunology Research.

Suppression of TNF-α-Induced Apoptosis by NF-κB

Seamus J. Martin, D. Green, I. Verma, 1996, Science.

Biodistribution and toxicity studies of VSVG-pseudotyped lentiviral vector after intravenous administration in mice with the observation of in vivo transduction of bone marrow.

I. Verma, T. Kafri, W. Kaemmerer, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Gene Therapy That Works

I. Verma, 2013, Science.

Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector

L Naldini, F. Gage, I. Verma, 1997, Journal of virology.

Biopiracy: distrust widens the rich-poor divide.

I. Verma, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme

I. Verma, Y. Soda, Amy Rommel, 2013, Journal of Molecular Medicine.

Transdifferentiation of glioblastoma cells into vascular endothelial cells

S. Pastorino, S. Kesari, D. Friedmann-Morvinski, 2011, Proceedings of the National Academy of Sciences.

Development of a novel mouse glioma model using lentiviral vectors

Miriam Scadeng, Inder M Verma, F. Gage, 2009, Nature Medicine.

Nucleotide sequence and formation of the transforming gene of a mouse sarcoma virus

Russell F. Doolittle, Inder M. Verma, R. Doolittle, 1981, Nature.

NF-κB regulation in the immune system

Inder M. Verma, I. Verma, Qiutang Li, 2002, Nature Reviews Immunology.

Induction of the proto-oncogene fos by nerve growth factor.

I. Verma, D. Schubert, W. Kruijer, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Role of Rel/NF-κB transcription factors during the outgrowth of the vertebrate limb

I. Verma, Y. Kanegae, A. T. Tavares, 1998, Nature.

Microarray and cDNA sequence analysis of transcription during nerve-dependent limb regeneration

Tony Hunter, Inder M Verma, Gerald M Pao, 2009, BMC Biology.

Induction of proto-oncogene JUN/AP-1 by serum and TPA

I. Verma, P. Sassone-Corsi, W. Lamph, 1988, Nature.

Regulation of proto-oncogene fos: a paradigm for early response genes.

I. Verma, P. Sassone-Corsi, W. Lamph, 1988, Cold Spring Harbor symposia on quantitative biology.

c-fos protein can induce cellular transformation: A novel mechanism of activation of a cellular oncogene

T. Curran, I. Verma, A. Miller, 1984, Cell.

Expression of cellular oncogenes in human malignancies.

I. Verma, D. Slamon, J. Dekernion, 1984, Science.

Expression of c‐onc genes: c‐fos transcripts accumulate to high levels during development of mouse placenta, yolk sac and amnion.

I. Verma, E. Adamson, R. Müller, 1983, The EMBO journal.

Rapid induction of the expression of proto-oncogene fos during human monocytic differentiation

R. Schreiber, R. Mitchell, I. Verma, 1985, Cell.

Detection of a transforming gene product in cells transformed by Moloney murine sarcoma virus

Inder M. Verma, Tony Hunter, T. Hunter, 1982, Cell.

Proto‐oncogene fos: Factors Affecting Expression and Covalent Modification of the Gene Product

I. Verma, P. Sassone-Corsi, J. Barber, 1987, Annals of the New York Academy of Sciences.

Tissue and cell type-specific expression of two human c-onc genes

I. Verma, E. Adamson, R. Müller, 1983, Nature.

Viral and cellular fos proteins are complexed with a 39,000-dalton cellular protein

T. Curran, I. Verma, C. V. van Beveren, 1985, Molecular and cellular biology.

Viral and cellular fos proteins: A comparative analysis

I. Verma, Dusty Miller, L. Zokas, 1984, Cell.

Expression of cellular oncogenes.

I. Verma, R. Müller, 1984, Current topics in microbiology and immunology.

Inflammation-associated cancer: NF-κB is the lynchpin

I. Verma, S. Withoff, Qiutang Li, 2005 .

Inflammation-associated cancer: NF-kappaB is the lynchpin.

I. Verma, S. Withoff, Qiutang Li, 2005, Trends in immunology.

Heteroduplex analysis of the sequence relations between the RNAs of mink cell focus-inducing and murine leukemia viruses

Y. Chien, E. Scolnick, I. Verma, 1978, Journal of virology.

Genome organization of retroviruses. VI. Heteroduplex analysis of ecotropic and xenotropic sequences of moloney mink cell focus-inducing viral RNA obtained from either a cloned isolate or a thymoma cell line

I. Verma, L. V. van Griensven, M. Vogt, 1979, Journal of virology.

FBJ murine osteosarcoma virus: identification and molecular cloning of biologically active proviral DNA

T. Curran, I. Verma, C. V. van Beveren, 1982, Journal of virology.

Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment.

F. Chisari, I. Verma, K. Bissig, 2010, The Journal of clinical investigation.

Differential expression of cellular oncogenes during pre- and postnatal development of the mouse

I. Verma, D. Slamon, R. Müller, 1982, Nature.

IKK1-deficient mice exhibit abnormal development of skin and skeleton.

I. Verma, Qiutang Li, Qingxian Lu, 1999, Genes & development.

A heteroduplex study of the sequence relationships between the RNAs of M-MSV and M-MLV

I. Verma, N. Davidson, Sylvia Hu, 1977, Cell.

Generation of a stable cell line producing high-titer self-inactivating lentiviral vectors.

I. Verma, H. Ma, T. Kafri, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Gene therapy: promises and problems.

I. Verma, A. Pfeifer, Inder M. Verma, 2001, Annual review of genomics and human genetics.

Hybrid Periportal Hepatocytes Regenerate the Injured Liver without Giving Rise to Cancer

K. Deisseroth, Brian Hsueh, H. Carter, 2015, Cell.

Expression of the c-fos gene and of an fos-related gene is stimulated by platelet-derived growth factor.

I. Verma, C. Stiles, B. Cochran, 1984, Science.

Introduction of rat growth hormone gene into mouse fibroblasts via a retroviral DNA vector: expression and regulation.

R. Evans, M. Rosenfeld, M. Barinaga, 1982, Proceedings of the National Academy of Sciences of the United States of America.

Lentiviral vectors, two decades later

I. Verma, D. Trono, L. Naldini, 2016, Science.

Identification of therapeutic targets for glioblastoma by network analysis

S. Subramaniam, D. Friedmann-Morvinski, I. Verma, 2016, Oncogene.

Mesenchymal high-grade glioma is maintained by the ID-RAP1 axis.

K. Aldape, A. Iavarone, P. Zoppoli, 2013, The Journal of clinical investigation.

Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma.

A. Regev, X. Zhuang, I. Tirosh, 2021, Cancer cell.

Glioblastoma Model Using Human Cerebral Organoids

Inder M Verma, Gerald M Pao, I. Verma, 2018, Cell reports.

Pharmacological activation of REV-ERBs is lethal in cancer and oncogene induced senescence

A. Saghatelian, S. Panda, I. Verma, 2018, Nature.

A High Proliferation Rate Is Required for Cell Reprogramming and Maintenance of Human Embryonic Stem Cell Identity

Juan Carlos Izpisua Belmonte, Inder M. Verma, A. D. Panopoulos, 2011, Current Biology.

Dovitinib enhances temozolomide efficacy in glioblastoma cells

I. Verma, S. Ghavami, T. Klonisch, 2017, Molecular oncology.

Detection of fos protein during osteogenesis by monoclonal antibodies

P. Sawchenko, I. Verma, H. Niman, 1988, Molecular and cellular biology.

The mouse c-rel protein has an N-terminal regulatory domain and a C-terminal transcriptional transactivation domain

T. Hunter, I. Verma, M. Hoekstra, 1990, Molecular and cellular biology.

mXBP/CRE-BP2 and c-Jun form a complex which binds to the cyclic AMP, but not to the 12-O-tetradecanoylphorbol-13-acetate, response element

I. Verma, L. Glimcher, L. Ivashkiv, 1990, Molecular and cellular biology.

ras-induced neuronal differentiation of PC12 cells: possible involvement of fos and jun

C. Der, I. Verma, P. Sassone-Corsi, 1989, Molecular and cellular biology.

Fos-Jun interaction: mutational analysis of the leucine zipper domain of both proteins.

J. Visvader, I. Verma, P. Sassone-Corsi, 1989, Genes & development.

Direct interaction between fos and jun nuclear oncoproteins: role of the 'leucine zipper' domain

I. Verma, P. Sassone-Corsi, W. Lamph, 1988, Nature.

fos-associated cellular p39 is related to nuclear transcription factor AP-1

I. Verma, P. Sassone-Corsi, W. Lamph, 1988, Cell.

Transcriptional autoregulation of the proto-oncogene fos

I. Verma, P. Sassone-Corsi, J. Sisson, 1988, Nature.

Platelet-derived growth factor induces rapid but transient expression of the c-fos gene and protein

Jonathan A. Cooper, T. Hunter, I. Verma, 1984, Nature.

Disease-corrected haematopoietic progenitors from Fanconi anaemia induced pluripotent stem cells

A. Consiglio, Á. Raya, I. Verma, 2009, Nature.

Characterization of RACK7 as a Novel Factor Involved in BRCA1 Mutation Mediated Breast Cancer

I. Verma, Quan-sheng Zhu, M. Preyer, 2012 .

Enhancement of BRCA1 E3 Ubiquitin Ligase Activity through Direct Interaction with the BARD1 Protein*

Tony Hunter, Inder M Verma, Gerald M Pao, 2003, The Journal of Biological Chemistry.

Transcriptional activation by BRCA1

I. Verma, M. Chapman, 1996, Nature.

CBP/p300 interact with and function as transcriptional coactivators of BRCA1.

H. Ruffner, T. Hunter, I. Verma, 2000, Proceedings of the National Academy of Sciences of the United States of America.

BRCA1 is a cell cycle-regulated nuclear phosphoprotein.

H. Ruffner, I. Verma, Inder M. Verma, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation

D. Gutmann, D. Friedmann-Morvinski, I. Verma, 2016, Oncotarget.

Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model

Inder M Verma, F. Gage, E. Masliah, 2005, Nature Neuroscience.

Development of a Self-Inactivating Lentivirus Vector

Fred H. Gage, Hiroyuki Miyoshi, Inder M. Verma, 1998, Journal of Virology.

Truncated BRCA2 is cytoplasmic: implications for cancer-linked mutations.

F. Gage, I. Verma, F. Gage, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Suppression of PPAR-γ attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes

I. Verma, J. Olefsky, T. Imamura, 2007 .

A combination therapy for KRAS-driven lung adenocarcinomas using lipophilic bisphosphonates and rapamycin

E. Oldfield, I. Verma, Xiaoying Zhou, 2014, Science Translational Medicine.

Muscle-specific transcriptional activation by MyoD.

S. Tapscott, H. Weintraub, R. Davis, 1991, Genes & development.

BRCA2 cooperates with histone acetyltransferases in androgen receptor-mediated transcription

I. Verma, Sook Shin, 2003, Proceedings of the National Academy of Sciences of the United States of America.

LFG: an anti-apoptotic gene that provides protection from Fas-mediated cell death.

S. Heinemann, I. Verma, D. V. Van Antwerp, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Inhibition of TNF-induced apoptosis by NF-κB

Seamus J. Martin, D. Green, I. Verma, 1998 .

Heterochromatin-Encoded Satellite RNAs Induce Breast Cancer.

Karen H. Miga, J. Yates, T. Hunter, 2018, Molecular cell.

Sustained suppression of Bcr-Abl-driven lymphoid leukemia by microRNA mimics

Inder M Verma, I. Verma, O. Witte, 2007, Proceedings of the National Academy of Sciences.

A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA

Inder M Verma, I. Verma, M. Ikawa, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Analysis of FBJ-MuSV provirus and c-fos (mouse) gene reveals that viral and cellular fos gene products have different carboxy termini

T. Curran, I. Verma, Rolf Muller, 1983, Cell.

Nuclear proto-oncogenes fos and jun.

I. Verma, Inder M. Verma, L. Ransone, 1990, Annual review of cell biology.

Structure of the FBJ murine osteosarcoma virus genome: molecular cloning of its associated helper virus and the cellular homolog of the v-fos gene from mouse and human cells

T. Curran, I. Verma, Inder M. Verma, 1983, Molecular and cellular biology.

Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element.

J. Visvader, I. Verma, P. Sassone-Corsi, 1988, Genes & development.

Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinoma

I. Verma, Joep Beumer, Eugene Ke, 2015, Proceedings of the National Academy of Sciences.

Tumor suppressor protein (p)53, is a regulator of NF-κB repression by the glucocorticoid receptor

Sumit K. Chanda, Inder M. Verma, A. Orth, 2011, Proceedings of the National Academy of Sciences.

Regulation of β-Catenin Function by the IκB Kinases*

R. Gaynor, S. Byers, I. Verma, 2001, The Journal of Biological Chemistry.

Tumor necrosis factor alpha-induced phosphorylation of I kappa B alpha is a signal for its degradation but not dissociation from NF-kappa B.

I. Verma, M. Maki, S. Miyamoto, 1994, Proceedings of the National Academy of Sciences of the United States of America.

IκBγ, a 70 kd protein identical to the C-terminal half of p110 NF-κB: A new member of the IκB family

I. Verma, J. Inoue, A. Kakizuka, 1992, Cell.

The rel-associated pp40 protein prevents DNA binding of Rel and NF-kappa B: relationship with I kappa B beta and regulation by phosphorylation.

I. Verma, H. Bose,, J. Inoue, 1991, Genes & development.

Functional antagonism between c-Jun and MyoD proteins: A direct physical association

S. Tapscott, R. Scharfmann, H. Weintraub, 1992, Cell.

Glyoxalase 1 and glutathione reductase 1 regulate anxiety in mice

Eric E. Schadt, David J. Lockhart, Inder M. Verma, 2005, Nature.

A Fourth IκB Protein within the NF-κB Signaling Module

Hana Kim, Alexander Hoffmann, Vinay Tergaonkar, 2007, Cell.

Gene therapy with viral vectors.

I. Verma, N. Kootstra, 2003, Annual review of pharmacology and toxicology.

Applications of gene therapy to the CNS.

F. Gage, I. Verma, D. Trono, 1996, Human molecular genetics.

Recombinant Retroviruses in Transgenic Mice a

I. Verma, A. Miller, H. Fan, 1986, Annals of the New York Academy of Sciences.

Homology among oncogenes.

I. Verma, C. V. van Beveren, C. Van Beveren, 1986, Current topics in microbiology and immunology.

Infectious and selectable retrovirus containing an inducible rat growth hormone minigene.

R. Evans, M. Rosenfeld, I. Verma, 1984, Science.

Nucleotide sequence of the genome of a murine sarcoma virus

I. Verma, C. Beveren, J. Galleshaw, 1981, Cell.

Analysis of the env gene of a molecularly cloned and biologically active Moloney mink cell focus-forming proviral DNA

I. Verma, C. V. van Beveren, Inder M. Verma, 1982, Journal of virology.

Gene Therapy: Medicine of the 21stCentury

I. Verma, 2003 .

Long-term expression of a retrovirally introduced β-galactosidase gene in rodent cells implanted in vivo using biodegradable polymer meshes

R. Scharfmann, I. Verma, Yifan Dai, 1992, Somatic cell and molecular genetics.

Opportunities for the use of lentiviral vectors in human gene therapy.

I. Verma, F. Galimi, Inder M. Verma, 2002, Current topics in microbiology and immunology.

Identification of a nuclear targeting sequence in the Fos protein.

I. Verma, I. Tratner, 1991, Oncogene.

Production and purification of lentiviral vectors

I. Verma, O. Singer, G. Tiscornia, 2006, Nature Protocols.

CRE recombinase-inducible RNA interference mediated by lentiviral vectors.

I. Verma, F. Galimi, V. Tergaonkar, 2004, Proceedings of the National Academy of Sciences of the United States of America.

Transgenesis by lentiviral vectors: Lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos

I. Verma, M. Ikawa, A. Pfeifer, 2002, Proceedings of the National Academy of Sciences of the United States of America.

Lentiviral short hairpin ribonucleic acid-mediated knockdown of GLUT4 in 3T3-L1 adipocytes.

I. Verma, J. Olefsky, T. Imamura, 2006, Endocrinology.

Rapid generation of knockdown transgenic mice by silencing lentiviral vectors

I. Verma, M. Ikawa, O. Singer, 2006, Nature Protocols.

Silence of the genes.

I. Verma, O. Singer, A. Yanai, 2004, Proceedings of the National Academy of Sciences of the United States of America.

A Structural Basis for IκB Kinase 2 Activation Via Oligomerization-Dependent Trans Auto-Phosphorylation

A. Hoffmann, I. Verma, G. Ghosh, 2013, PLoS biology.

IKK biology

I. Verma, Fei Liu, Yifeng Xia, 2012, Immunological reviews.

IκB Kinase-Independent IκBα Degradation Pathway: Functional NF-κB Activity and Implications for Cancer Therapy

I. Verma, M. Ikawa, Qiutang Li, 2003, Molecular and Cellular Biology.

p53 stabilization is decreased upon NFκB activation

G. Wahl, I. Verma, O. Vafa, 2002 .

Bimp1, a MAGUK Family Member Linking Protein Kinase C Activation to Bcl10-mediated NF-κB Induction*

T. Mak, I. Verma, J. Ruland, 2001, The Journal of Biological Chemistry.

Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation.

A. Israël, I. Verma, Qiutang Li, 2000, Genes & development.

Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene

Inder M. Verma, Kuo-Fen Lee, I. Verma, 1999 .

Organization and Structure of Retrovirus Genomes

I. Verma, 1983 .

FBR murine osteosarcoma virus. II. Nucleotide sequence of the provirus reveals that the genome contains sequences acquired from two cellular genes.

T. Curran, I. Verma, C. V. van Beveren, 1984, Virology.

Both the basic region and the ‘leucine zipper’ domain of the cyclic AMP response element binding (CREB) protein are essential for transcriptional activation.

I. Verma, M. Montminy, V. Dwarki, 1990, The EMBO journal.

Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral vectors.

I. Verma, F. Galimi, M. Grompe, 2002, Blood.

Identification of a transcriptional enhancer element upstream from the proto-oncogene fos.

I. Verma, F. Meijlink, J. Deschamps, 1985, Science.

Genome organization of retroviruses. VII. Infection by double-stranded DNA synthesized in vitro from Moloney murine leukemia virus generates a virus indistinguishable from the original virus used in reverse transcription.

I. Verma, M. Lai, 1980, Virology.

Efficient and sustained gene transfer in terminally differentiated cells with a lentiviral vector

F. Gage, I. Verma, L. Naldini, 1997 .

3 Development of Lentiviral Vectors

I. Verma, G. Tiscornia, 2007 .

Development of Lentiviral Vectors Expressing siRNA

I. Verma, O. Singer, G. Tiscornia, 2007 .

Lentiviral vectors for retrograde delivery of recombinases and transactivators.

Ian R. Wickersham, H. Seung, H. A. Sullivan, 2015, Cold Spring Harbor protocols.

Genome organization of RNA tumor viruses II. Physical maps of in vitro-synthesized Moloney murine leukemia virus double-stranded DNA by restriction endonucleases

I. Verma, M. McKennett, 1978, Journal of virology.

Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants.

R. Scharfmann, I. Verma, J. Axelrod, 1991, Proceedings of the National Academy of Sciences of the United States of America.

The proto-oncogene BCL-3 encodes an IκB protein

G. Nabel, I. Verma, C. Duckett, 1992 .

Bcl-xL protects adult septal cholinergic neurons from axotomized cell death.

F. Gage, I. Verma, T. Kafri, 1998, Proceedings of the National Academy of Sciences of the United States of America.

“Green light” for gene transfer

I. Verma, 1996, Nature Biotechnology.

Inhibitors of NF-κB Activity

I. Verma, Qiutang Li, V. Tergaonkar, 2006 .

Transduction of liver cells by lentiviral vectors: analysis in living animals by fluorescence imaging.

I. Verma, N. Kootstra, R. Hoffman, 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

Retroviral Vector Targeting to Human Immunodeficiency Virus Type 1-Infected Cells by Receptor Pseudotyping

I. Verma, H. Miyoshi, N. Somia, 2000, Journal of Virology.

Long terminal repeat of murine retroviral DNAs: sequence analysis, host-proviral junctions, and preintegration site

D. Lowy, I. Verma, C. V. van Beveren, 1982, Journal of virology.

Reverse transcriptase is coded for by the viral RNA.

I. Verma, E. Hunter, 1975, Bibliotheca haematologica.

Role of the subunits of the avian RNA tumor virus reverse transcriptase.

D. Baltimore, I. Verma, A. Panet, 1975, Cold Spring Harbor symposia on quantitative biology.

Generation of disease-free hematopoietic progenitors from Fanconi anemia-specific induced pluripotent stem cells

A. Consiglio, Á. Raya, I. Verma, 2009 .

Identification and molecular cloning of Moloney mouse sarcoma virus-specific sequences from uninfected mouse cells

I. Verma, A. Berns, H. Fan, 1980 .

Signal-dependent and -independent Degradation of Free and NF-κB-bound IκBα*

Inder M. Verma, I. Verma, M. Pando, 2000, The Journal of Biological Chemistry.

Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required

I. Verma, D. V. Van Antwerp, D. V. Antwerp, 1996, Molecular and cellular biology.

Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells

I. Verma, N. Kootstra, Nina Tonnu, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Proto-oncogene fos: Complex but versatile regulation

I. Verma, P. Sassone-Corsi, 1987, Cell.

Expression of human alpha-globin and mouse/human hybrid beta-globin genes in murine hemopoietic stem cells transduced by recombinant retroviruses.

I. Verma, V. Dwarki, C. Li, 1990, Proceedings of the National Academy of Sciences of the United States of America.

Gene therapy for thioguanine-resistant human leukemia.

I. Verma, S. Howell, M. Murphy, 1987, Molecular biology & medicine.

Analysis of transforming gene products from moloney murine sarcoma virus

Inder M. Verma, Tony Hunter, T. Hunter, 1981, Cell.

Identification of a RNA polymerase II initiation site in the long terminal repeat of Moloney murine leukemia viral DNA.

I. Verma, C. V. van Beveren, S. Fuhrman, 1981, Proceedings of the National Academy of Sciences of the United States of America.

Nucleotide sequence of Moloney leukemia virus: 3' end reveals details of replications, analogy to bacterial transposons, and an unexpected gene.

R. Lerner, J. Sutcliffe, I. Verma, 1980, Proceedings of the National Academy of Sciences of the United States of America.

The fos oncogene.

I. Verma, Inder M. Verma, W. R. Graham, 1987, Advances in cancer research.

Covalently linked RNA-DNA molecule as initial product of RNA tumour virus DNA polymerase.

D. Baltimore, K. Manly, I. Verma, 1971, Nature: New biology.

Suppression of angiogenesis by lentiviral delivery of PEX, a noncatalytic fragment of matrix metalloproteinase 2.

I. Verma, D. Cheresh, A. Pfeifer, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Piecing together more efficient gene expression

I. Verma, T. Kafri, N. Somia, 1999, Nature Biotechnology.

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression.

N. Sarvetnick, I. Verma, E. Schwarz, 1995, Proceedings of the National Academy of Sciences of the United States of America.

Phosphorylation of p53 by IκB kinase 2 promotes its degradation by β-TrCP

I. Verma, V. Bottero, V. Tergaonkar, 2009, Proceedings of the National Academy of Sciences.

Size analysis and relationship of murine leukemia virus-specific mRNA's: evidence for transposition of sequences during synthesis and processing of subgenomic mRNA

I. Verma, H. Fan, 1978, Journal of Virology.

In vitro synthesis of DNA complementary to rabbit reticulocyte 10S RNA.

G. Temple, D. Baltimore, I. Verma, 1972, Nature: New biology.

vectors Gene therapy of Fanconi anemia: preclinical efficacy using lentiviral

I. Verma, F. Galimi, M. Grompe, 2013 .

Corrigendum: Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model

E. Oldfield, I. Verma, R. Shaw, 2015, Nature Cell Biology.

Reduced cell proliferation by IKK2 depletion in a mouse lung cancer model

E. Oldfield, I. Verma, R. Shaw, 2012, Nature Cell Biology.

Long-term lowering of plasma cholesterol levels in LDL-receptor-deficient WHHL rabbits by gene therapy.

I. Verma, H. Kankkonen, S. Ylä-Herttuala, 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

Efficient transduction of liver and muscle after in utero injection of lentiviral vectors with different pseudotypes.

G. Kobinger, I. Verma, N. Kootstra, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Lentiviral vectors: regulated gene expression.

F. Gage, I. Verma, H. van Praag, 2000, Molecular therapy : the journal of the American Society of Gene Therapy.

Targeting CREB Pathway Suppresses Small Cell Lung Cancer

I. Verma, Mathias Leblanc, C. Zhan, 2018, Molecular Cancer Research.

Direct gene transfer to the liver with herpes simplex virus type 1 vectors: transient production of physiologically relevant levels of circulating factor IX.

I. Verma, T. Friedmann, J. Witztum, 1992, The New biologist.

Circadian clock protein cryptochrome regulates the expression of proinflammatory cytokines

S. Panda, I. Verma, Fei Liu, 2012, Proceedings of the National Academy of Sciences.

Constitutive phosphorylation of IcBa by casein kinase II

I. Verma, E. Schwarz, C. Barroga, 2016 .

Complete nucleotide sequence of a human c-onc gene: deduced amino acid sequence of the human c-fos protein.

T. Curran, I. Verma, R. Müller, 1983, Proceedings of the National Academy of Sciences of the United States of America.

The NIH Roadmap

Inder M. Verma, I. Verma, 2004 .

Genic regions of a large salamander genome contain long introns and novel genes

Wei Zhu, Timothy T Harkins, Tony Hunter, 2009, BMC Genomics.

Rel/NF-kappa B/I kappa B story.

I. Verma, S. Miyamoto, Inder M. Verma, 1995, Advances in cancer research.

NF-kappaB and the regulation of hematopoiesis.

I. Verma, S. Withoff, V. Bottero, 2006, Cell death and differentiation.

Severe liver degeneration in mice lacking the IkappaB kinase 2 gene.

I. Verma, F. Mercurio, D. V. Van Antwerp, 1999, Science.

Are the benefits of stem cells being oversold?

I. Verma, 2001, Molecular Therapy.

Distinct roles of IκB proteins in regulating constitutive NF-κB activity

I. Verma, M. Ikawa, R. G. Correa, 2005, Nature Cell Biology.

Zebrafish IkappaB kinase 1 negatively regulates NF-kappaB activity.

Concepción Rodríguez-Esteban, I. Verma, R. G. Correa, 2005, Current biology : CB.

Distinct roles of IkappaB proteins in regulating constitutive NF-kappaB activity.

I. Verma, M. Ikawa, R. G. Correa, 2005, Nature cell biology.

Characterization of NF-kappa B/I kappa B proteins in zebra fish and their involvement in notochord development.

I. Verma, R. G. Correa, V. Tergaonkar, 2004, Molecular and cellular biology.

Regulating the Master Regulator NF-_B: From Natural Strategies to Rationally Designed Superdrugs

Vinay Tergaonkar, Inder M. Verma, Sebo Withoff, 2006 .

Functional Gene Correction for Cystic Fibrosis in Lung Epithelial Cells Generated from Patient iPSCs.

F. Gage, I. Verma, A. Firth, 2015, Cell reports.

Transformation by FosB requires a trans-activation domain missing in FosB2 that can be substituted by heterologous activation domains.

I. Verma, R. Wisdom, D. Rashid, 1992, Genes & development.

Removal of an mRNA destabilizing element correlates with the increased oncogenicity of proto-oncogene fos.

I. Verma, I M Verma, V Raymond, 1989, Oncogene research.

Tumor Suppressor p53 Functions as a Negative Regulator in IgE-Mediated Mast Cell Activation

I. Verma, Kotaro Suzuki, Fei Liu, 2011, PloS one.

Size determination of mitochondrial ribosomal RNA from Aspergillus nidulans by electron microscopy.

M. Edelman, I. Verma, M. Herzberg, 1970, Journal of molecular biology.

Physico-chemical properties of mitochondrial ribosomal RNA from fungi.

M. Edelman, I. Verma, E. Galun, 1971, European journal of biochemistry.

Mitochondrial ribosomal RNA from Aspergillus nidulans: characterization of a novel molecular species.

M. Edelman, I. Verma, U. Z. Littauer, 1970, Journal of molecular biology.

Genetic manipulation of the optical refractive index in living cells

A. Miyawaki, I. Verma, G. Pao, 2020, bioRxiv.

NF-κB and the regulation of hematopoiesis

I. Verma, S. Withoff, V. Bottero, 2006, Cell Death and Differentiation.

Modeling Gliomas Using Two Recombinases.

I. Verma, T. Hara, 2019, Cancer research.

c-fos promoter transactivation by the tax , protein of human T-cell leukemia virus type I ( transcription / regulatory elements / oncogenesis )

I. Verma, P. Sassone-Corsi, M. Fujii, 2022 .

A Fourth IkB Protein within the NF-kB Signaling Module

A. Hoffmann, C. Benedict, C. Ware, 2007 .

Qualitative changes in the subunit composition of kappa B-binding complexes during murine B-cell differentiation.

I. Verma, S. Miyamoto, M. Schmitt, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Enhanced I kappa B alpha degradation is responsible for constitutive NF-kappa B activity in mature murine B-cell lines

I. Verma, P. Chiao, S. Miyamoto, 1994, Molecular and cellular biology.

Moloney murine leukemia virus-induced tumors: recombinant proviruses in active chromatin regions.

W. Quint, I. Verma, A. Berns, 1982, Nucleic acids research.

Little evidence of bone marrow-derived hepatocytes in the replacement of injured liver

I. Verma, Y. Kanazawa, 2003, Proceedings of the National Academy of Sciences of the United States of America.

Regulated lentiviral NGF gene transfer controls rescue of medial septal cholinergic neurons.

Ronald W. Alfa, M. Tuszynski, I. Verma, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

Development of ecdysone-regulated lentiviral vectors.

R. Evans, I. Verma, J. Gall, 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

BRCA1/BARD1-dependent ubiquitination of NF2 regulates Hippo-YAP1 signaling

J. Diedrich, I. Verma, G. Pao, 2019, Proceedings of the National Academy of Sciences.

Establishment of human iPSC-based models for the study and targeting of glioma initiating cells

G. Wahl, D. O'Leary, I. Sancho-Martinez, 2016, Nature Communications.

Suppression of PPAR-gamma attenuates insulin-stimulated glucose uptake by affecting both GLUT1 and GLUT4 in 3T3-L1 adipocytes.

I. Verma, J. Olefsky, T. Imamura, 2007, American journal of physiology. Endocrinology and metabolism.

Cytoplasmic catalytic subunit of protein kinase A mediates cross-repression by NF-kappa B and the glucocorticoid receptor.

R. Evans, I. Verma, Y. Shi, 2000, Proceedings of the National Academy of Sciences of the United States of America.

AIDS: Modern concepts and therapeutic challenges Edited by S. Broder. New York: Marcel Dekker, Inc. (1987). 369 pp. $69.75

I. Verma, 1987, Cell.

Gene delivery of human apolipoprotein E alters brain Abeta burden in a mouse model of Alzheimer's disease.

Inder M Verma, Seema Malkani, S. Paul, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Two adjacent promoter elements mediate nerve growth factor activation of the c-fos gene and bind distinct nuclear complexes.

J. Visvader, I. Verma, P. Sassone-Corsi, 1988, Proceedings of the National Academy of Sciences of the United States of America.

Peripheral Delivery of a CNS Targeted, Metalo-Protease Reduces Aβ Toxicity in a Mouse Model of Alzheimer's Disease

E. Masliah, I. Verma, E. Rockenstein, 2011, PloS one.

Long-term neprilysin gene transfer is associated with reduced levels of intracellular Abeta and behavioral improvement in APP transgenic mice

F. Gage, E. Masliah, I. Verma, 2008, BMC Neuroscience.

Neprilysin regulates amyloid β peptide levels

F. Gage, L. Hersh, E. Masliah, 2007, Journal of Molecular Neuroscience.

Neprilysin Gene Transfer Reduces Human Amyloid Pathology in Transgenic Mice

F. Gage, L. Hersh, E. Masliah, 2003, The Journal of Neuroscience.

Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease.

I. Verma, M. Kindy, Jin Yu, 2008, The American journal of pathology.

Direct association of pp40/I kappa B beta with rel/NF-kappa B transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity.

I. Verma, J. Inoue, Inder M. Verma, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Editorial Expression of Concern: Experimental evidence of massivescale emotional contagion through social networks

I. Verma, 2014, Proceedings of the National Academy of Sciences.

Human xeno-autoantibodies against a non-human sialic acid serve as novel serum biomarkers and immunotherapeutics in cancer.

X. Chen, Yu-Tseung Liu, A. Varki, 2011, Cancer research.

IκB kinase: Beginning, not the end

Inder M. Verma, I. Verma, J. Stevenson, 1997 .

The Common Thread: A Story of Science, Politics, Ethics and the Human Genome

I. Verma, 2002, Nature Medicine.

Neprilysin regulates amyloid Beta peptide levels.

F. Gage, L. Hersh, E. Masliah, 2004, Journal of molecular neuroscience : MN.

Positive control mutations in the MyoD basic region fail to show cooperative DNA binding and transcriptional activation in vitro.

P. Rangarajan, H. Weintraub, I. Verma, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Structural Basis for the Activation of IKK1/ alpha.

I. Verma, G. Ghosh, D. Lyumkis, 2016 .

Reverse transcriptase of RNA tumor viruses. V. In vitro proteolysis of reverse transcriptase from avian myeloblastosis virus and isolation of a polypeptide manifesting only RNase H activity

I. Verma, M. Lai, 1978, Journal of virology.

Avian Myeloblastosis Virus DNA Polymerase

D. Baltimore, I. Verma, D. Smoler, 1973 .

The bZIP domains of Fos and Jun mediate a physical association with the TATA box-binding protein.

I. Verma, L. Ransone, L. Kerr, 1993, Gene expression.

Role of BRCA1 in brain development

F. Gage, D. O'Leary, I. Verma, 2014, Proceedings of the National Academy of Sciences.

A role for bone marrow-derived cells in the vasculature of noninjured CNS.

F. Gage, R. Summers, I. Verma, 2005, Blood.

Identification of 14-3-3sigma mutation causing cutaneous abnormality in repeated-epilation mutant mouse.

I. Verma, Qiutang Li, Qingxian Lu, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Inflammatory tales of liver cancer.

A. Hoffmann, I. Verma, Yifeng Xia, 2007, Cancer cell.

EGFR-induced and PKCε monoubiquitylation-dependent NF-κB activation upregulates PKM2 expression and promotes tumorigenesis.

K. Aldape, Yu Cao, I. Verma, 2012, Molecular cell.

Impact, not impact factor

Inder M Verma, I. Verma, 2015, Proceedings of the National Academy of Sciences.

Antiapoptotic protein Lifeguard is required for survival and maintenance of Purkinje and granular cells

D. O'Leary, I. Verma, Tatiana Hurtado de Mendoza, 2011, Proceedings of the National Academy of Sciences.

Human c-fos oncogene mapped within chromosomal region 14q21----q31.

F. Ruddle, I. Verma, W. R. Breg, 1984, Proceedings of the National Academy of Sciences of the United States of America.

EGFR-Induced and PKCε Monoubiquitylation-Dependent NF-κB Activation Upregulates PKM2 Expression and Promotes Tumorigenesis.

K. Aldape, I. Verma, P. Chiao, 2018, Molecular cell.

Gene transfer and gene therapy

A. Beaudet, I. Verma, R. Mulligan, 1988 .

Reciprocity between phase shifts and amplitude changes in the mammalian circadian clock

Satchidananda Panda, Inder M Verma, David K Welsh, 2007, Proceedings of the National Academy of Sciences.

Matrix metalloproteinase/integrin interactions as target for anti-angiogenic treatment strategies.

A. Pfeifer, I. Verma, D. Cheresh, 2002, Annals of hematology.

Overexpression of the FosB2 gene in thymocytes causes aberrant development of T cells and thymic epithelial cells

I. Verma, A. Berns, H. Jacobs, 1997, Oncogene.

Macroporous Dual-compartment Hydrogels for Minimally Invasive Transplantation of Primary Human Hepatocytes

I. Verma, S. Varghese, Yu-Ru V. Shih, 2018, Transplantation.

3 Lentiviral Vectors

I. Verma, L. Naldini, 1999 .

Transformation by Jun: requirement for leucine zipper, basic region and transactivation domain and enhancement by Fos.

I. Verma, P. Vogt, T. Bos, 1992, Oncogene.

Neprilysin protects neurons against Aβ peptide toxicity

F. Gage, I. Verma, M. Kindy, 2007, Brain Research.

IkappaB kinase: beginning, not the end.

I. Verma, J. Stevenson, 1997, Proceedings of the National Academy of Sciences of the United States of America.

GENOME ORGANIZATION OF RETROVIRUSES IV. PHYSICAL MAPPING OF MURINE SARCOMA VIRUS AND HETERODUPLEX ANALYSIS OF RECOMBINANT MURINE LEUKEMIA VIRUSES

I. Verma, N. Davidson, C. Roberts, 1979 .

Immunotherapeutics in Cancer Acid Serve as Novel Serum Biomarkers and Human Xeno-Autoantibodies against a Non-Human Sialic

X. Chen, Yu-Tseung Liu, A. Varki, 2011 .

Molecular cloning of unintegrated Moloney mouse sarcoma virus DNA in bacteriophage lambda.

I. Verma, A. Berns, H. Fan, 1980, Proceedings of the National Academy of Sciences of the United States of America.

Time varying causal network reconstruction of a mouse cell cycle

S. Subramaniam, M. Maurya, I. Verma, 2019, BMC Bioinform..

[43] Ultraviolet cross-linking of DNA binding proteins

I. Verma, S. Miyamoto, K. Cauley, 1995 .

Diverse molecular mechanisms of inhibition of NF-kappa B/DNA binding complexes by I kappa B proteins.

I. Verma, T. Léveillard, 1993, Gene expression.

Corrigendum: Reduced cell proliferation by IKK2 depletion in a mouse lung-cancer model

E. Oldfield, I. Verma, R. Shaw, 2015, Nature Cell Biology.

Potential of adenovirus as a vector for sustained gene expression

I. Verma, 1999, Journal of Gene Medicine.

Making the promise a reality.

I. Verma, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

BRCA 1 tumor suppression occurs via heterochromatin mediated silencing

F. Gage, P. Nederlof, I. Verma, 2011 .

Imaging heterochromatin in human embryonic stem cells with light-sheet Bayesian microscopy

I. Verma, Quan-sheng Zhu, J. Fitzpatrick, 2013, Epigenetics & Chromatin.

PNAS introduces new magazine section

David J Harris, Inder M Verma, I. Verma, 2013, Proceedings of the National Academy of Sciences.

Time varying causal network reconstruction of a mouse cell cycle

Mano Ram Maurya, Shankar Subramaniam, Maryam Masnadi-Shirazi, 2019, BMC Bioinformatics.

Microarray and cDNA sequence analysis of transcription during nerve-dependent limb regeneration

S. Bryant, T. Harkins, T. Hunter, 2009, BMC Biology.

Developmental expression of the Xenopus laevis fos protooncogene.

I. Verma, M. Kindy, 1990, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

Gene therapy: the need for basic science.

I. Verma, 2000, Molecular Therapy.

Association of nuclear oncoproteins fos and jun.

I. Verma, L. Ransone, 1989, Current opinion in cell biology.

Design and Cloning of an shRNA into a Lentiviral Silencing Vector: Version B.

I. Verma, O. Singer, G. Tiscornia, 2008, CSH protocols.

Design and Cloning of an shRNA into a Lentiviral Silencing Vector: Version A.

I. Verma, O. Singer, G. Tiscornia, 2008, CSH protocols.

Preprint servers facilitate scientific discourse

Inder M Verma, I. Verma, 2017, Proceedings of the National Academy of Sciences.

PNAS at 101: Heading into the next century

I. Verma, 2016, Proceedings of the National Academy of Sciences.

BRCA1 tumor suppression occurs via heterochromatin mediated silencing

F. Gage, P. Nederlof, I. Verma, 2011, Nature.

Neprilysin protects neurons against Abeta peptide toxicity.

F. Gage, I. Verma, M. Kindy, 2007, Brain research.

NF-κB, an Active Player in Human Cancers

I. Verma, Yifeng Xia, Shen Shen, 2014, Cancer Immunology Research.

Activation of Transcription Factor NF-κB Requires ELKS, an IκB Kinase Regulatory Subunit

A. Shevchenko, I. Verma, V. Bottero, 2004, Science.

Screening for tumor suppressors: Loss of ephrin receptor A2 cooperates with oncogenic KRas in promoting lung adenocarcinoma

I. Verma, Eugene Ke, Yifeng Xia, 2015, Proceedings of the National Academy of Sciences.

Correction for Agemy et al., Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma

E. Ruoslahti, D. Friedmann-Morvinski, I. Verma, 2014, Proceedings of the National Academy of Sciences.

NF-?B regulation in the immune system

I. Verma, Qiutang Li, 2002 .

Lentiviral vectors for retrograde delivery of recombinases and transactivators.

Ian R. Wickersham, H. Seung, I. Verma, 2015, Cold Spring Harbor protocols.

Kappa B enhancer-binding complexes that do not contain NF-kappa B are developmentally regulated in mammalian brain.

I. Verma, K. Cauley, 1994, Proceedings of the National Academy of Sciences of the United States of America.

The autoregulated instability of Polo-like kinase 4 limits centrosome duplication to once per cell cycle.

I. Verma, Quan-sheng Zhu, E. Nigg, 2012, Genes & development.

Supplemental Information Structural Basis for the Activation of IKK1/a

I. Verma, G. Ghosh, D. Lyumkis, 2016 .

I kappa B gamma, a 70 kd protein identical to the C-terminal half of p110 NF-kappa B: a new member of the I kappa B family.

I. Verma, J. Inoue, A. Kakizuka, 1992, Cell.